NCT06430853
Psychobiological Interventions in Pregnancy
Enrolling by Invitation
NAAges 18+InterventionalTreatmentStanford UniversityInvestigator-initiated
~88 participants
Updated 2026-05-15 on ClinicalTrials.gov
What's tested:Step count goalActigraph watch
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Edinburgh Postpartum Depression Scale (EPDS) Score
Measured over Randomization around 20 weeks gestation and end of study (around 37 weeks gestation).
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Study leadership
- Danielle M Panelli, MD, MS · PRINCIPAL_INVESTIGATOR · Stanford University
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Able to read and write in English or Spanish
Presenting for a prenatal visit with a viable singleton gestation (no known lethal fetal anomaly or plan for pregnancy termination) between 18 and 20 weeks 0 days
Any history of depression or anxiety, defined as: 1) documented depression or anxiety in the medical record within the preceding 2 years; 2) baseline EPDS score \>=10 at intake prenatal visit; 3) baseline EPDS anxiety subscale 3A score \>=5
Exclusion
Known allergy to steel or rubber
Implantable medical device
Contraindication to physical activity such as a pre-existing cardiovascular condition or arrhythmia
Plan to relocate and/or deliver at another institution
Concurrent severe mental illness (diagnosis of bipolar disorder or schizophrenia)
Known lethal fetal anomaly or nonviable pregnancy
Baseline \>30 min per week of vigorous physical activity (from Pregnancy Physical Activity Questionnaire, PPAQ)
What this trial measures
- Change in Edinburgh Postpartum Depression Scale (EPDS) ScoreRandomization around 20 weeks gestation and end of study (around 37 weeks gestation).
The mean within person change in EPDS score between randomization and the end of the study will be compared between the 2 arms. The EPDS is a 10-question validated measure with a score range of 0-30 for depression and/or anxiety screening in pregnancy that has been translated into many languages. A score of \>=10 has been shown to be consistent with depressive symptoms.